Company intelligence / Profile preview

The Gnomon Group

Ownership: Private
Development stage: Other

Overview

The Gnomon Group is a consulting firm founded in 2007 by Mike Dalton and Tom Schumaker. It specializes in providing senior regulatory strategy support, document formatting, eSubmission publishing, and submission management for pharmaceutical companies—especially startups and small to mid-sized firms. Their work includes supporting pre-IND communications with the FDA for investigational products. They do not have their own clinical pipeline or proprietary therapeutics.

Industry: Consulting

Partnerships

Nesvik Pharmaceuticals/BioStem Technologies

Beyond the preview

Go deeper on The Gnomon Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Gnomon Group.

Explore the full profile